ArticleTranslational andrology and urology2025
Personalized prediction for recurrence of cystitis glandularis: insights from SHAP and machine learning models.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence for the prediction of prognosis in colorectal cancer patients using routine blood indices.NPJ digital medicine · 2026Article
- Research on a machine learning-based predictive model for postoperative neurological dysfunction in acute Stanford type A aortic dissection.Frontiers in medicine · 2026Article
- A machine learning-based predictive model for postoperative pulmonary complications in lung cancer and its SHAP interpretation.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cystitis glandularis (CG) is a rare urological condition characterized by glandular metaplasia of the bladder mucosa. Recurrence following transurethral resection (TUR) is a significant clinical challenge. Traditional predictive models often fail to capture the complexity of the data, resulting in insufficient accuracy. In contrast, machine learning (ML) has demonstrated substantial potential in medical prediction by identifying and analyzing complex patterns that are undetectable by conventional methods. This study aims to develop and evaluate an interpretable ML model to predict recurrence after TUR for CG, thereby improving clinical decision-making and patient outcomes. Methods: We analyzed predictors of recurrence using the least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression. We developed and tested seven ML-based models: Cox proportional hazards model (CoxPH), LASSO regression, decision tree (rpart), random survival forest (RSF), gradient boosting machine (GBM), support vector machine (SVM), and extreme gradient boosting (XGBoost). Participants were diagnosed with CG by pathology following TUR and treated from 2012 to 2018. Model discrimination was assessed using the receiver operating characteristic (ROC) curve and area under the ROC curve (AUC), while model preference was evaluated through the Brier score (BS). Decision curve analysis (DCA) was used for model comparison. The SHapley Additive exPlanations (SHAP) method was employed for interpretation, providing insights into recurrence prediction and prevention strategies. Finally, user-friendly platform was developed, allowing users to predict CG recurrence by entering feature values into designated text boxes on the webpage. Results: The RSF model demonstrated the best performance in predicting recurrence, as indicated by superior ROC, DCA, and BS metrics. In SHAP, postoperative regular instillation (PRI) contributed the most to model construction. Conclusions: The RSF model effectively predicts CG recurrence, offering a framework for individualized treatment strategies. PRI was identified as the most significant risk factor influencing recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.